Kura Oncology, Inc.

KURA

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001422143

SEC filings (opens in a new tab)

In the last 90 days, Kura Oncology, Inc. insiders filed 2 open-market purchases and 8 sales; 221 institutions reported holding it in 13F filings for Q2 2026, worth $953.1M in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Kura Oncology, Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024 All holders in Q1 2024

13F holders of KURA: Q1 2024 compared with Q2 2024
Measure	Q1 2024	Of which not filed for Q2 2024	Q2 2024	Change
Holders	165	1	174	+10
Shares	80.8M	72.5K	80.5M	−193.8K (−0.2%)
Value	$1.72B	$1.55M	$1.66B	−$63.2M (−3.7%)

1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (29)

Institutions that held Kura Oncology, Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to KURA in Q2 2024
Institution	Shares	Value	% of portfolio
Deep Track Capital, LP	384,756	$7.92M	0.24%
Ameriprise Financial Inc	182,557	$3.76M	0.00%
Woodline Partners LP	143,207	$2.95M	0.03%
Exome Asset Management LLC	131,742	$2.71M	2.42%
Integral Health Asset Management, LLC	100,000	$2.06M	0.20%
Eversept Partners, LP	72,317	$1.49M	0.11%
HRT Financial LP	43,702	$899.0K	0.01%
Mirae Asset Global ETFs Holdings Ltd.	40,484	$833.1K	0.00%
Corebridge Financial, Inc.	39,010	$803.2K	0.00%
Superstring Capital Management LP	36,242	$746.2K	0.94%
J. Goldman & Co LP	32,721	$673.7K	0.03%
Marshall Wace, LLP	26,267	$540.8K	0.00%
Fox Run Management, L.L.C.	24,340	$501.2K	0.09%
Prelude Capital Management, LLC	23,700	$488.0K	0.04%
Connor, Clark & Lunn Investment Management Ltd.	21,933	$451.6K	0.00%
HighVista Strategies LLC	16,764	$345.2K	0.13%
Capstone Investment Advisors, LLC	13,517	$278.3K	0.01%
Allianz Asset Management GmbH	10,500	$216.2K	0.00%
Knott David M Jr	10,000	$206.0K	0.08%
Bellevue Group AG	10,000	$205.9K	0.00%
Quarry LP	9,500	$195.6K	0.08%
Catalyst Funds Management Pty Ltd	3,000	$61.8K	0.02%
Smartleaf Asset Management LLC	185	$3.79K	0.00%
Parallel Advisors, LLC	172	$3.54K	0.00%
Global Retirement Partners, LLC	142	$2.92K	0.00%
Strategic Investment Solutions, Inc.	100	$2.08K	0.00%
Innealta Capital, LLC	54	$1.11K	0.00%
SRS Capital Advisors, Inc.	26	$536	0.00%
Massmutual Trust Co FSB	19	$391	0.00%

Sold out (19)

Institutions that held Kura Oncology, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of KURA in Q2 2024
Institution	Shares, Q1 2024	Value, Q1 2024
Logos Global Management LP	300,000	$6.40M
Cubist Systematic Strategies, LLC	109,161	$2.33M
Lighthouse Investment Partners, LLC	58,967	$1.26M
Perceptive Advisors LLC	48,200	$1.03M
Qube Research & Technologies Ltd	35,548	$758.2K
American International Group, Inc.	34,775	$741.8K
Cinctive Capital Management LP	29,543	$630.2K
Susquehanna Fundamental Investments, LLC	23,754	$506.7K
Simplex Trading, LLC	23,746	$506.0K
Fred Alger Management, LLC	18,079	$385.6K
E Fund Management Co., Ltd.	14,710	$313.8K
Campbell & CO Investment Adviser LLC	13,339	$284.5K
Entropy Technologies, LP	10,215	$217.9K
Graham Capital Management, L.P.	10,172	$217.0K
Saxon Interests, Inc.	9,420	$200.9K
SG Americas Securities, LLC	5,174	$110.0K
Metropolitan Life Insurance Co	3,719	$79.3K
Group One Trading, L.P.	2,125	$45.3K
Nelson, Van Denburg & Campbell Wealth Management Group, LLC	14	$298

Not filed for Q2 2024 yet (1)

Institutions that held Kura Oncology, Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding KURA in Q1 2024 that haven't filed for Q2 2024
Institution	Shares, Q1 2024	Value, Q1 2024
Credit Suisse AG	72,494	$1.55M